Tertomotide Not Yet Recruiting Phase 2 Trials for Mild to Moderate Alzheimer's Disease Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05189210GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)